CAS: 2284621-75-4
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | 6-(4-((5-Chloro-4-((4-chlorophenyl)amino)pyrimidin-2-yl)amino)-1H-pyrazol-1-yl)-N-hydroxyhexanamide REF: IN-DA01V549CAS: 2284621-75-4 | 98.53% | A consultar | Vie 29 Nov 24 |
 | JAK/HDAC-IN-1 REF: 3D-JRD62175CAS: 2284621-75-4 | Min. 95% | A consultar | Vie 10 Ene 25 |
 | 6-(4-((5-Chloro-4-((4-chlorophenyl)amino)pyrimidin-2-yl)amino)-1H-pyrazol-1-yl)-N-hydroxyhexanamide REF: 10-F546403CAS: 2284621-75-4 | 98.0% | - - - | Producto descatalogado |
6-(4-((5-Chloro-4-((4-chlorophenyl)amino)pyrimidin-2-yl)amino)-1H-pyrazol-1-yl)-N-hydroxyhexanamide
CAS:2284621-75-4
Fórmula:
C19H21Cl2N7O2
Pureza:
98.53%
Peso molecular:
450.3217
Ref: IN-DA01V549
| 1mg | 212,00 € | ||
| 5mg | 605,00 € | ||
| 10mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Viernes 29 de Noviembre de 2024
JAK/HDAC-IN-1
CAS:2284621-75-4
Please enquire for more information about JAK/HDAC-IN-1 including the price, delivery time and more detailed …
Fórmula:
C19H21Cl2N7O2
Pureza:
Min. 95%
Peso molecular:
450.32 g/mol
Ref: 3D-JRD62175
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Viernes 10 de Enero de 2025
6-(4-((5-Chloro-4-((4-chlorophenyl)amino)pyrimidin-2-yl)amino)-1H-pyrazol-1-yl)-N-hydroxyhexanamide
CAS:2284621-75-4
Pureza:
98.0%
Peso molecular:
450.32000732421875
Ref: 10-F546403
| 1g | Descatalogado | Solicitar información | |
| 250mg | Descatalogado | Solicitar información |
